Publications database

The 2012 EMCDDA work programme takes forward activities begun in 2010 to implement the EMCDDA's three-year strategy (2010–12). This strategy seeks to: consolidate and deepen the analysis of core datasets held at...

EU Member States classify drugs and precursors according to the three UN Conventions of 1961, 1971 and 1988 (abbreviated below to UN61, UN71 and UN88), controlling and supervising their legitimate scientific or...

The Instrument of Pre-accession Assistance (IPA) 4 is implemented by the EMCDDA. The project is financed through the Instrument of Pre-accession Assistance (IPA) of Directorate- General Enlargement of the European Commission. It...

In response to a notified increase in HIV cases among injecting drug users (IDU) in Greece and Romania, the European Commission asked the European Centre for Disease Prevention and Control (ECDC) and...

This joint publication with the European Police Agency, Europol, is an in-depth study on the illicit market in amphetamine. Bringing together data on law enforcement measures such as drug seizures and clandestine...

This Manual is a joint production by the EMCDDA and the Prevention Standards Partnership, and presents and describes basic and expert level quality standards for drug prevention. The standards cover all aspects...

This country overview provides a structured synopsis of the trends and characteristics of national drug problems in Kosovo (under UNSCR 1244/99) in 2010. It consists of a summary of the national drug...

This briefing paper describes some of the practical and legal obstacles facing Member States when responding to such new substances. It underlines the importance of national early-warning systems in detecting and identifying...

The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in...

This Selected issue provides an exploratory European overview of costs associated with treatment for drug dependence. The cost of drug treatment in Europe is looked at from two main angles in this...